Spanish firm CLH Group has secured a contract to operate and extend the existing fuel storage terminal at Dublin airport, following a tender process organised by Daa.

The company will manage the storage facility under a concession scheme for 20 years and will also expand its capacity and build a new hydrant system.

During the 2016-2018 period, CLH said that the investment will exceed €40m, with the aim of commissioning new infrastructures in stages, for which completion is expected in three years.

The new facility will comprise three storage tanks of 5,000 cubic metres each, office and service buildings, parking area, pumping stations, into-plane fuelling unit loading areas and advanced safety systems.

Chairman of CLH, José Luis López de Silanes, said: “This transaction consolidates the company’s internationalisation strategy through a growing industry such as the supply of aviation fuel, where the CLH Group has broad knowledge.”

In Association with

Jorge Lanza, CEO of CLH, added: “The transaction is an exciting challenge involving the operation and renovation of the fuel storage terminal of an important airport as Dublin, while keeping the facility operational at all times, as with the project we undertook a few years back at Alicante airport.”

To execute the project and operate the new plant, the CLH Group created a new company under the name of CLH Aviation Ireland Ltd, 100% owned by CLH Aviación.

CLH is the leading company in the transport and storage of oil products in the Spanish market. The company’s infrastructure in Spain consists of over 4,000 kilometres of oil pipelines and 40 storage facilities, with a capacity of 8 million cubic metres, in addition to 28 airport facilities.

The company also operates in the United Kingdom through its subsidiary, CLH-PS, and is developing a major project in the Sultanate of Oman.

Photo: L-R Jorge Lanza, CEO of CLH Group, Vincent Harrison, MD of Dublin Airport, José Luis López de Silanes, chairman of CLH Group, José María Rodríguez, Spanish ambassador to Ireland, and Salvador Guillén, MD of CLH Group